SCHEMBL6094828

SCHEMBL6094828

O=C1C=C(O)C(=O)C(c2c(C3CC3)[nH]c3ccccc23)=C1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
PADI4 Q9UM07 4/20 0.37
RAB9A P51151 5/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
MAPT P10636 4/20 0.36
CCNB2 O95067 2/20 0.36
CDK1 P06493 2/20 0.36
CDK4 P11802 2/20 0.36
CCNB1 P14635 2/20 0.36
CCNA2 P20248 2/20 0.36
CCND1 P24385 2/20 0.36
CCNE1 P24864 2/20 0.36
CDK2 P24941 2/20 0.36
MAPK1 P28482 2/20 0.36
GSK3A P49840 2/20 0.36
GSK3B P49841 2/20 0.36
CDK9 P50750 2/20 0.36
CDK5 Q00535 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6110147 0.79 CCR6 (0.51) NPC1MEN1KMT2ARAB9AMAPT
SCHEMBL6093878 0.79 PTPRC (0.54) MEN1KMT2APADI4MAPTTDP1
SCHEMBL6096623 0.77 ALDH1A1 (0.39) NPC1MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL6095875 0.76 XIAP (0.41) NPC1MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL6094612 0.76 KDM4E (0.40) NPC1MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL6096689 0.76 HPGD (0.40) NPC1MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL6096773 0.75 AURKA (0.34) MEN1KMT2APADI4RAB9ASMN1; SMN2
SCHEMBL6095918 0.74 TSHR (0.38) NPC1MEN1KMT2APADI4RAB9A
SCHEMBL8601530 0.73 MEN1 (0.39) NPC1MEN1KMT2APADI4RAB9A
SCHEMBL7038193 0.70 ESR1 (0.61) NPC1MEN1KMT2APADI4RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7057052-B2 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY (US) 2006-06-06 US disclosed
WO-2004050014-A2 SETEROCYCLIC QUINONES AS PHARMACEUTICAL AGENTS DUKE UNIVERSITY (US) 2004-06-17 WO disclosed
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY 2004-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents NQO1, RECQL, SDHA NPC1 1217/4885MEN1 726/4885KMT2A 2003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.